Celestica Inc
CLS NYSE Printed Circuit Boards Financials FY2022–FY2025
Last close · Oct 23, 2026
$260.01
3.3%What Celestica Inc does
No business description yet.
- Legal name
- CELESTICA INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 27, 2026
- Accession · CIK
- 0001030894-26-000011
0001030894
Revenue and margins
Celestica Inc had $12.4B of revenue in fiscal 2025, up 28.5% on the year before.
Net income and earnings per share
From fiscal 2022 to 2025, diluted EPS grew 69.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $458M in fiscal 2025, 3.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Celestica Inc returned $153M to shareholders in fiscal 2025, 33% of free cash flow. The diluted share count fell 2.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Celestica Inc can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $375M | $370M | $423M | $596M |
| Debt incl. finance leases | — | $743M | $858M | $835M |
| Net debt / EBITDA | — | 0.8x | 0.6x | 0.2x |
| Debt / equity | — | 0.4x | 0.4x | 0.4x |
| Interest coverage | 5.6x | 4.3x | 11.5x | 19.8x |
| Current ratio | — | 1.4x | 1.5x | 1.4x |
| Quick ratio | — | 0.7x | 0.9x | 0.9x |
| Total assets | — | $5.9B | $6.0B | $7.2B |
| Total liabilities | — | $4.1B | $4.1B | $5.0B |
| Shareholders' equity | $1.7B | $1.8B | $1.9B | $2.2B |
| Net debt (− = net cash) | — | $373M | $435M | $239M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | — | ✓ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✕ |
| Debt fell relative to assets | — | — | ✕ | ✓ |
| Current ratio rose | — | — | ✓ | ✕ |
| Share count didn't rise | — | ✓ | ✓ | ✓ |
| Gross margin rose | — | ✓ | ✓ | ✓ |
| Revenue rose relative to assets | — | — | ✓ | ✓ |
| F-score | — / 3 | — / 5 | 8 / 9 | 7 / 9 |
| Accruals ratio | — | −1.4% | −0.8% | 2.6% |
| Altman Z'' | — | 1.80 | 2.56 | 3.20 |
4 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $7.3B | $8.0B | $9.6B | $12.4B |
| Gross profit | $650M | $754M | $1.0B | $1.5B |
| Research and development | $46.3M | $60.9M | $78.0M | $118M |
| Operating income | $289M | $338M | $599M | $1.0B |
| Interest expense | $51.7M | $78.9M | $52.1M | $52.6M |
| Pretax income | $239M | $306M | $532M | $983M |
| Income tax | $59.0M | $61.6M | $104M | $151M |
| Net income | $180M | $244M | $428M | $833M |
| Diluted EPS | $1.46 | $2.03 | $3.61 | $7.16 |
| Diluted shares | 0.12B | 0.12B | 0.12B | 0.12B |
| Cash flow | ||||
| Cash from operations | $211M | $326M | $474M | $660M |
| Capital expenditure | $109M | $125M | $171M | $201M |
| Free cash flow | $102M | $201M | $303M | $458M |
| Depreciation and amortization | $116M | $131M | $152M | $176M |
| Stock-based compensation | $51.0M | $55.6M | $57.4M | $69.8M |
| Acquisitions | $0.0M | $0.0M | $36.1M | $0.0M |
| Share buybacks | $34.6M | $35.6M | $152M | $153M |
| Dividends and buybacks | $34.6M | $35.6M | $152M | $153M |
| Balance sheet | ||||
| Cash and short-term investments | $375M | $370M | $423M | $596M |
| Total debt | — | $675M | $797M | $777M |
| Finance lease liabilities | — | $68.0M | $61.7M | $58.0M |
| Current assets | — | $4.5B | $4.5B | $5.7B |
| Current liabilities | — | $3.2B | $3.0B | $3.9B |
| Inventory | — | $2.1B | $1.8B | $2.2B |
| Goodwill | $322M | $322M | $341M | $333M |
| Intangible assets | — | $318M | $308M | $266M |
| Total assets | — | $5.9B | $6.0B | $7.2B |
| Total liabilities | — | $4.1B | $4.1B | $5.0B |
| Shareholders' equity | $1.7B | $1.8B | $1.9B | $2.2B |
| Margins | ||||
| Gross margin | 9.0% | 9.5% | 10.7% | 12.1% |
| Operating margin | 4.0% | 4.2% | 6.2% | 8.4% |
| EBITDA margin | 5.6% | 5.9% | 7.8% | 9.8% |
| Net margin | 2.5% | 3.1% | 4.4% | 6.7% |
| FCF margin | 1.4% | 2.5% | 3.1% | 3.7% |
| Returns | ||||
| Return on capital | — | 13.0% | 21.2% | 36.8% |
| Return on capital employed | — | 12.7% | 20.2% | 31.8% |
| Return on equity | 10.7% | 14.2% | 23.3% | 40.5% |
| Return on assets | — | 4.1% | 7.2% | 12.6% |
| Return on tangible equity | 13.3% | 21.6% | 34.3% | 51.5% |
| Growth | ||||
| Revenue growth | — | 9.8% | 21.2% | 28.5% |
| Net income growth | — | 35.7% | 75.1% | 94.5% |
| EPS growth | — | 39.0% | 77.8% | 98.3% |
| FCF growth | — | 97.0% | 50.7% | 51.3% |
| Share count change | — | −2.7% | −1.3% | −2.1% |
| Financial health | ||||
| Net debt / EBITDA | — | 0.8x | 0.6x | 0.2x |
| Debt / equity | — | 0.4x | 0.4x | 0.4x |
| Interest coverage | 5.6x | 4.3x | 11.5x | 19.8x |
| Current ratio | — | 1.4x | 1.5x | 1.4x |
| Quick ratio | — | 0.7x | 0.9x | 0.9x |
| Capital allocation | ||||
| Capex / revenue | 1.5% | 1.6% | 1.8% | 1.6% |
| Stock comp / revenue | 0.7% | 0.7% | 0.6% | 0.6% |
| Payouts / FCF | 33.9% | 17.7% | 50.2% | 33.5% |
| Quality scores | ||||
| Piotroski F-score | — | — | 8.0 | 7.0 |
| Altman Z'' | — | 1.8 | 2.6 | 3.2 |
| Accruals ratio | — | −1.4% | −0.8% | 2.6% |
Source: SEC EDGAR XBRL filings (CIK 0001030894). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
